Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GABRG2 | P18507 | 13/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 13/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 12/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 12/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 12/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 11/20 | 0.46 |
| ▸ | GABRA6 | Q16445 | 10/20 | 0.46 |
| ▸ | GABRA4 | P48169 | 5/20 | 0.46 |
| ▸ | GABRP | O00591 | 1/20 | 0.46 |
| ▸ | GABRD | O14764 | 1/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | GABRE | P78334 | 1/20 | 0.46 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.46 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.46 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL645688 | 1.00 | KDM4E (0.55) | KDM4EALDH1A1GABRG2GABRB3GABRA1 | |
| SCHEMBL13177597 | 0.87 | KDM4E (0.51) | KDM4EALDH1A1GABRG2GABRB3GABRA1 | |
| SCHEMBL27141575 | 0.84 | KDM4E (0.49) | KDM4EALDH1A1GABRG2GABRB3GABRA1 | |
| SCHEMBL13732052 | 0.82 | GABRG2 (0.49) | GABRG2GABRB3GABRA1GABRA2GABRA5 | |
| SCHEMBL8037078 | 0.81 | GABRG2 (0.47) | KDM4EALDH1A1GABRG2GABRB3GABRA1 | |
| SCHEMBL30978460 | 0.80 | MAPK1 (0.65) | KDM4EALDH1A1GABRG2GABRB3GABRA1 | |
| SCHEMBL109364 | 0.80 | MAPK1 (0.65) | KDM4EALDH1A1GABRG2GABRB3GABRA1 | |
| SCHEMBL31723056 | 0.79 | GABRG2 (0.57) | GABRG2GABRB3GABRA1GABRA2GABRA5 | |
| SCHEMBL30556510 | 0.79 | GABRG2 (0.46) | ALDH1A1GABRG2GABRB3GABRA1GABRA2 | |
| SCHEMBL15956221 | 0.79 | GABRG2 (0.46) | ALDH1A1GABRG2GABRB3GABRA1GABRA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| WO-2025262295-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025262297-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| EP-4667467-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | Dark Blue Therapeutics Ltd (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-4667466-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | Dark Blue Therapeutics Ltd (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | NSUN3, BCAT1, SLC43A1 | KDM4E 671/4885ALDH1A1 2330/4885GABRG2 2305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.